These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 25444756)

  • 1. Targeting breast cancer through its microenvironment: current status of preclinical and clinical research in finding relevant targets.
    Nienhuis HH; Gaykema SB; Timmer-Bosscha H; Jalving M; Brouwers AH; Lub-de Hooge MN; van der Vegt B; Overmoyer B; de Vries EG; Schröder CP
    Pharmacol Ther; 2015 Mar; 147():63-79. PubMed ID: 25444756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the TGFβ pathway for cancer therapy.
    Neuzillet C; Tijeras-Raballand A; Cohen R; Cros J; Faivre S; Raymond E; de Gramont A
    Pharmacol Ther; 2015 Mar; 147():22-31. PubMed ID: 25444759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted and intracellular triggered delivery of therapeutics to cancer cells and the tumor microenvironment: impact on the treatment of breast cancer.
    Moura V; Lacerda M; Figueiredo P; Corvo ML; Cruz ME; Soares R; de Lima MC; Simões S; Moreira JN
    Breast Cancer Res Treat; 2012 May; 133(1):61-73. PubMed ID: 21805188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of inflammatory microenvironment: potential implications for improved breast cancer nano-targeted therapy.
    Lan M; Lu W; Zou T; Li L; Liu F; Cai T; Cai Y
    Cell Mol Life Sci; 2021 Mar; 78(5):2105-2129. PubMed ID: 33386887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer metastasis.
    Scully OJ; Bay BH; Yip G; Yu Y
    Cancer Genomics Proteomics; 2012; 9(5):311-20. PubMed ID: 22990110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Therapeutic Potential of Targeting Tumor Microenvironment in Breast Cancer: Rational Strategies and Recent Progress.
    Bahrami A; Hassanian SM; Khazaei M; Hasanzadeh M; Shahidsales S; Maftouh M; Ferns GA; Avan A
    J Cell Biochem; 2018 Jan; 119(1):111-122. PubMed ID: 28574616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted drug delivery for breast cancer treatment.
    Jin S; Ye K
    Recent Pat Anticancer Drug Discov; 2013 May; 8(2):143-53. PubMed ID: 23394116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage Polarization: Anti-Cancer Strategies to Target Tumor-Associated Macrophage in Breast Cancer.
    Tariq M; Zhang J; Liang G; Ding L; He Q; Yang B
    J Cell Biochem; 2017 Sep; 118(9):2484-2501. PubMed ID: 28106295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Advances In Developing Novel Anti-Cancer Drugs Targeting Tumor Hypoxic and Acidic Microenvironments.
    Li W; Sun X
    Recent Pat Anticancer Drug Discov; 2018; 13(4):455-468. PubMed ID: 30173649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of nanoparticle drug delivery systems responsive to endogenous breast cancer microenvironment.
    Zou T; Lu W; Mezhuev Y; Lan M; Li L; Liu F; Cai T; Wu X; Cai Y
    Eur J Pharm Biopharm; 2021 Sep; 166():30-43. PubMed ID: 34098073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting mitochondrial function for the treatment of breast cancer.
    Deus CM; Coelho AR; Serafim TL; Oliveira PJ
    Future Med Chem; 2014 Sep; 6(13):1499-513. PubMed ID: 25365234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor microenvironment: driving forces and potential therapeutic targets for breast cancer metastasis.
    Xie HY; Shao ZM; Li DQ
    Chin J Cancer; 2017 Mar; 36(1):36. PubMed ID: 28356139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-stroma crosstalk: targeting stroma in breast cancer.
    Criscitiello C; Esposito A; Curigliano G
    Curr Opin Oncol; 2014 Nov; 26(6):551-5. PubMed ID: 25279962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
    Gacche RN; Meshram RJ
    Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel antiangiogenic drugs for the management of breast cancer: new approaches for an old issue?
    Bozza C; Fontanella C; Buoro V; Mansutti M; Aprile G
    Expert Rev Clin Pharmacol; 2015 Mar; 8(2):251-65. PubMed ID: 25597501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-associated fibroblasts: a multifaceted driver of breast cancer progression.
    Luo H; Tu G; Liu Z; Liu M
    Cancer Lett; 2015 Jun; 361(2):155-63. PubMed ID: 25700776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Huaier extract suppresses breast cancer via regulating tumor-associated macrophages.
    Li Y; Qi W; Song X; Lv S; Zhang H; Yang Q
    Sci Rep; 2016 Feb; 6():20049. PubMed ID: 26831282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signaling pathways in breast cancer: therapeutic targeting of the microenvironment.
    Nwabo Kamdje AH; Seke Etet PF; Vecchio L; Muller JM; Krampera M; Lukong KE
    Cell Signal; 2014 Dec; 26(12):2843-56. PubMed ID: 25093804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory and microenvironmental factors involved in breast cancer progression.
    Ham M; Moon A
    Arch Pharm Res; 2013 Dec; 36(12):1419-31. PubMed ID: 24222504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of tumor microenvironment by chemopreventive natural products.
    Park SA; Surh YJ
    Ann N Y Acad Sci; 2017 Aug; 1401(1):65-74. PubMed ID: 28640929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.